Dihydro-beta-ergocryptine mesylate

Known as: Dihydro-.beta.-ergocryptine mesylate 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1972-2009
02419722009

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
In t h ~ s paper, the dynamics of T:S:P ratio and of total alkaloid content Itas reg~stsred. for Clavlceps pzrrpureu sclerot~a of… (More)
  • table 1
Is this relevant?
2004
2004
In recent years, effective preparations based on 2-bromo-Q-ergocryptine with neurohormonal activity have been marketed: Parlodel… (More)
Is this relevant?
1988
1988
Starting from the structural analogy between bromo-ergocryptine (Parlodel) and dihydroergocryptine caffeine (Vasobral), as well… (More)
Is this relevant?
1978
1978
Various ergot alkaloids and derivatives were investigated for their interaction with dopaminergic receptors at the level of the… (More)
Is this relevant?
1978
1978
Between 5 and 10% of all young girls and women suffer of severe primary dysmenorrhoea which interfers monthly with their… (More)
Is this relevant?
1977
1977
Seven women with amenorrhea and galactorrhea, and no evidence of pituitary adenoma, were treated with brom-ergocryptine for two… (More)
Is this relevant?
1975
1975
Administration of Brom-ergocryptine (CB-154) has a dramatic effect on breast secretion. Inhibition of lactation occurs within… (More)
Is this relevant?
1975
1975
1975
The mechanism and hormonal regulation of lactation is explained and illustrated with a schematic representation. Circulating… (More)
Is this relevant?